ARCHIVES

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says

October 17, 1997

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

September 3, 2010

Female Smokers Face Double Risk For Lung Cancer

July 28, 2006

HEW Approves New Cancer Clinical Education Grants, Without Trainee Stipends ; $4 Million Available In ’75

April 26, 1974

Rep. Regula To Lead House Labor, HHS; Specter Likely Senate Labor, HHS Chairman.

January 12, 2001

No Cancer Letter For Next Two Weeks

August 19, 1994